Dr. Fallah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10903 New Hampshire Ave
Silver Spring, MD 20903
Summary
- Hematology and Medical Oncology
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2017 - 2020
- Brown UniversityResidency, Internal Medicine, 2014 - 2017
- Isfahan University of Medical SciencesClass of 2010
Certifications & Licensure
- OH State Medical License 2017 - 2025
- RI State Medical License 2014 - 2017
- MA State Medical License 2015 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- ASCO Trainee Council Member 2019-2021
- 16th Annual AAADV Workshop Travel Scholarship 2019
- AACR associate member 2019
- Join now to see all
Clinical Trials
- NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma Start of enrollment: 2013 Jun 12
Publications & Presentations
PubMed
- 24 citationsOn the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment—Cytokines, Targeted Therapy, and ImmunotherapyJanice P. Dutcher, Ronan Flippot, Jaleh Fallah, Bernard Escudier
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2020-03-31 - 10 citationsMyeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall Survival.Jaleh Fallah, Claudia Marcela Diaz-Montero, Patricia Rayman, Wei Wei, James H. Finke
Clinical Genitourinary Cancer. 2020-03-19 - 54 citationsFDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer.Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, Mallorie H Fiero, Sriram Subramaniam
Clinical Cancer Research. 2023-05-01
Journal Articles
- The role of immunotherapy in the management of patients with renal cell carcinoma and brain metastasesJaleh Fallah, Manmeet S. Ahluwalia, Annals of Translational Medicine (ATM), 10/2019
- Relationship between negative affectivity and severity of irritable bowel syndrome (IBS) symptomsBagherian-Sararoudi R, Kalantari H, Afshar H, Daghaghzadeh H, Abotalebian F, Falah J, Adibi P, Journal of Babol University of Medical Sciences
Abstracts/Posters
- Circulating cell-free DNA (cfDNA) levels and fragmentation pattern can distinguish nonmuscle invasive (NMI) from muscle-invasive (MI) and metastatic (met) bladder canc...Jaleh Fallah, Shinjini Ganguly, Hong Li, Wei (Auston) Wei, Aysegul Balyimez, Thirunavukkarasu Sitalaximi, C. Marcela Diaz-Montero, Patricia A. Rayman, Marcelo Lamenza,..., Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 4523-4523.ASCO Annual Meeting 2019, Chicago, IL, 6/2019
- Association of cell-free DNA (cfDNA) levels with myeloid-derived suppressor cells (MDSC) levels in blood of patients (pts) with muscle invasive (MI) and metastatic (me...Jaleh Fallah, Shinjini Ganguly, Patricia A. Rayman, Wei (Auston) Wei, Aysegul Balyimez, Thirunavukkarasu Sitalaximi, Marcelo Lamenza, Kevin L. Stephans, Priscilla Dann..., Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019) 4528-4528. ASCO Annual Meeting 2019., Chicago, IL, 6/2019
- Neoadjuvant durvalumab +/-tremelimumab affects the expression of immune checkpoint molecules on myeloid derived suppressor cells in patients with locally advanced rena...Fallah J, Diaz-Montero CM, Rayman P, Wei W, Wood L, Martin A, Allman K, Gilligan T, Ornstein M, Garcia JA, Rini BI, GU-ASCO 2019 (Genitourinary Cancers Symposium), San Francisco, CA, 1/1/2019
- Join now to see all
Lectures
- Circulating cell-free DNA (cfDNA) levels and fragmentation pattern can distinguish nonmuscle invasive (NMI) from muscle-invasive (MI) and metastatic (met) bladder canc...ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Association of cell-free DNA (cfDNA) levels with myeloid-derived suppressor cells (MDSC) levels in blood of patients (pts) with muscle invasive (MI) and metastatic (me...ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Journal Club: Superiority clinical trial designCleveland Clinic, Taussig Cancer Institute - 11/15/2019
- Join now to see all
Authored Content
- The Importance of Myeloid-Derived Suppressor Cells in Oncology - Beyond the AbstractMay 2020
Press Mentions
- Second-Generation Androgen Receptor Inhibitors Supported for Older Nonmetastatic CRPC PatientsFebruary 8th, 2021
- Targeting the Sanctuary Site: Options When Breast Cancer Metastasizes to the BrainAugust 23rd, 2019
- Don’t Miss These Cleveland Clinic Cancer Center Presentations at the 2019 ASCO Annual MeetingMay 30th, 2019
- Join now to see all
Committees
- Review editor, Frontiers in Oncology - Genitourinary Oncology
Professional Memberships
- Member
- Member
Other Languages
- Farsi
External Links
- Linkedinhttps://www.linkedin.com/in/jaleh-fallah-2563a240/
- ResearchGatehttps://www.researchgate.net/profile/Jaleh_Fallah
- Loophttps://loop.frontiersin.org/people/802603/overview
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: